Skip to main content
. 2021 Jun 14;9(6):e002349. doi: 10.1136/jitc-2021-002349

Figure 2.

Figure 2

Clinical outcomes according to body mass index (BMI) and dosing strategy. (A) Progression-free survival with weight-based dosing; (B) progression-free survival with fixed dosing; (C) overall survival with weight-based dosing; (D) overall survival with fixed dosing.